SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-303146
Filing Date
2014-08-08
Accepted
2014-08-08 16:14:18
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d744643d10q.htm 10-Q 359144
2 EX-31.1 d744643dex311.htm EX-31.1 6362
3 EX-31.2 d744643dex312.htm EX-31.2 6715
4 EX-32.1 d744643dex321.htm EX-32.1 4208
5 EX-32.2 d744643dex322.htm EX-32.2 4163
  Complete submission text file 0001193125-14-303146.txt   2952261

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flxn-20140630.xml EX-101.INS 331187
7 XBRL TAXONOMY EXTENSION SCHEMA flxn-20140630.xsd EX-101.SCH 30064
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20140630_cal.xml EX-101.CAL 51189
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20140630_def.xml EX-101.DEF 102449
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20140630_lab.xml EX-101.LAB 274033
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20140630_pre.xml EX-101.PRE 193562
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 141027636
SIC: 2834 Pharmaceutical Preparations